Deep, qualified next-technology sequencing has unveiled that subclonal mutations (i.e., Individuals current in just a portion of tumor cells) could be detected for all driver genes and are affiliated with immediate disease progression and poor final result.11–thirteen This is particularly relevant for TP53 mutations specified the fact that, as di